Explore market opportunities by mastering the EU system for variations. Gain insights on optimizing regulatory procedures, crafting global dossiers, and achieving faster approvals. Enhance your ...
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) for the treatment of adult patients with HER2 ...